131 related articles for article (PubMed ID: 2997264)
1. Human T-cell leukemia/lymphoma virus I and/or Epstein-Barr virus-infected B-cell lines spontaneously produce acid-labile alpha-interferon.
Boumpas DT; Hooks JJ; Popovic M; Tsokos GC; Mann DL
J Clin Immunol; 1985 Sep; 5(5):340-4. PubMed ID: 2997264
[TBL] [Abstract][Full Text] [Related]
2. Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-I): impairment of T-cell control of Epstein-Barr virus-infected B-cells.
Katsuki T; Katsuki K; Imai J; Hinuma Y
Jpn J Cancer Res; 1987 Jul; 78(7):639-42. PubMed ID: 3040648
[TBL] [Abstract][Full Text] [Related]
3. Interferon production potentials of various human lymphoblastoid cell lines.
Matsuyama M; Sairenji T; Yonemura K; Hinuma Y
Microbiol Immunol; 1982; 26(12):1149-58. PubMed ID: 6188944
[TBL] [Abstract][Full Text] [Related]
4. Impairment of T-cell control of Epstein-Barr virus infected B-cells in patients with adult T-cell leukemia.
Katsuki T; Yamaguchi K; Matsuoka Y; Hinuma Y
AIDS Res; 1986 Dec; 2 Suppl 1():S125-30. PubMed ID: 3030343
[TBL] [Abstract][Full Text] [Related]
5. Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
Purtilo DT
AIDS Res; 1986 Dec; 2 Suppl 1():S1-6. PubMed ID: 2881552
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel HTLV-infected cell line.
Koeffler HP; Chen IS; Golde DW
Blood; 1984 Aug; 64(2):482-90. PubMed ID: 6331549
[TBL] [Abstract][Full Text] [Related]
7. HTLV-I infection of T and B cells of a patient with adult T-cell leukemia-lymphoma (ATLL) and transmission of HTLV-I from B cells to normal T cells.
Franchini G; Mann DL; Popovic M; Zicht RR; Gallo RC; Wong-Staal F
Leuk Res; 1985; 9(11):1305-14. PubMed ID: 3001435
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
Yarchoan R; Redfield RR; Broder S
J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
[TBL] [Abstract][Full Text] [Related]
9. [IFN production by Epstein-Barr virus in human mononuclear leukocytes and suppression of the virus-induced transformation by the endogenous interferon].
Kikuta H
Hokkaido Igaku Zasshi; 1986 Jan; 61(1):46-57. PubMed ID: 3009290
[TBL] [Abstract][Full Text] [Related]
10. Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus.
Sugamura K; Fujii M; Kannagi M; Sakitani M; Takeuchi M; Hinuma Y
Int J Cancer; 1984 Aug; 34(2):221-8. PubMed ID: 6088403
[TBL] [Abstract][Full Text] [Related]
11. T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.
Nowakowska J; Stuehler C; Egli A; Battegay M; Rauser G; Bantug GR; Brander C; Hess C; Khanna N
Cytotherapy; 2015 Sep; 17(9):1280-91. PubMed ID: 26276009
[TBL] [Abstract][Full Text] [Related]
12. Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans.
Lotz M; Tsoukas CD; Fong S; Dinarello CA; Carson DA; Vaughan JH
J Immunol; 1986 May; 136(10):3636-42. PubMed ID: 3009608
[TBL] [Abstract][Full Text] [Related]
13. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Morishima S; Nakamura S; Yamamoto K; Miyauchi H; Kagami Y; Kinoshita T; Onoda H; Yatabe Y; Ito M; Miyamura K; Nagai H; Moritani S; Sugiura I; Tsushita K; Mihara H; Ohbayashi K; Iba S; Emi N; Okamoto M; Iwata S; Kimura H; Kuzushima K; Morishima Y
Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317
[TBL] [Abstract][Full Text] [Related]
14. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
[TBL] [Abstract][Full Text] [Related]
15. Interferon production by Epstein-Barr virus in human mononuclear leukocytes.
Kikuta H; Mizuno F; Yano S; Osato T
J Gen Virol; 1984 Apr; 65 ( Pt 4)():837-41. PubMed ID: 6323626
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the defects responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished gamma interferon production in response to autologous stimulation.
Hasler F; Bluestein HG; Zvaifler NJ; Epstein LB
J Exp Med; 1983 Jan; 157(1):173-88. PubMed ID: 6294213
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.
Lay JD; Tsao CJ; Chen JY; Kadin ME; Su IJ
J Clin Invest; 1997 Oct; 100(8):1969-79. PubMed ID: 9329960
[TBL] [Abstract][Full Text] [Related]
18. In vitro infection of human B lymphocytes with adult T-cell leukemia virus.
Okada M; Koyanagi Y; Kobayashi N; Tanaka Y; Nakai M; Sano K; Takeuchi K; Hinuma Y; Hatanaka M; Yamamoto N
Cancer Lett; 1984 Feb; 22(1):11-21. PubMed ID: 6321019
[TBL] [Abstract][Full Text] [Related]
19. Suppressive effect of human natural killer cells on Epstein-Barr virus-induced immunoglobulin synthesis.
Kuwano K; Arai S; Munakata T; Tomita Y; Yoshitake Y; Kumagai K
J Immunol; 1986 Sep; 137(5):1462-8. PubMed ID: 3018077
[TBL] [Abstract][Full Text] [Related]
20. Defective control of Epstein-Barr virus-infected B cell growth in patients with X-linked lymphoproliferative disease.
Yasuda N; Lai PK; Rogers J; Purtlo DT
Clin Exp Immunol; 1991 Jan; 83(1):10-6. PubMed ID: 1846327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
